AT1 receptor antagonist candesartan attenuates genomic damage in peripheral blood lymphocytes of patients on maintenance hemodialysis treatment.
about
AT1 receptor antagonist candesartan attenuates genomic damage in peripheral blood lymphocytes of patients on maintenance hemodialysis treatment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
AT1 receptor antagonist candes ...... enance hemodialysis treatment.
@en
AT1 receptor antagonist candes ...... enance hemodialysis treatment.
@nl
type
label
AT1 receptor antagonist candes ...... enance hemodialysis treatment.
@en
AT1 receptor antagonist candes ...... enance hemodialysis treatment.
@nl
prefLabel
AT1 receptor antagonist candes ...... enance hemodialysis treatment.
@en
AT1 receptor antagonist candes ...... enance hemodialysis treatment.
@nl
P2093
P2860
P356
P1476
AT1 receptor antagonist candes ...... enance hemodialysis treatment.
@en
P2093
André Klassen
August Heidland
Clemens Grupp
Helga Stopper
Katarina Sebeková
Przemyslaw Rutkowski
Udo Bahner
P2860
P304
P356
10.1159/000326805
P577
2011-04-07T00:00:00Z